Joseph Edelman – INBX history
- Issuer:
- INHIBRX BIOSCIENCES INC
- Quarters tracked:
- 21 (Q2 2021 → Q2 2026)
- Current shares:
- 1,297,763
- Current value:
- $122.96M
- Peak shares:
- 4,256,104 (Q3 2023)
- Overall change:
- +43%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q2 2026 | 1,297,763 | $122.96M | $94.75 | -144,944 | -10% |
| Q1 2026 | 1,442,707 | $96.99M | $67.23 | -10,000 | -1% |
| Q4 2025 | 1,452,707 | $114.76M | $79.00 | +125,000 | +9% |
| Q3 2025 | 1,327,707 | $44.72M | $33.68 | +349,815 | +36% |
| Q2 2025 | 977,892 | $13.96M | $14.27 | -86,134 | -8% |
| Q1 2025 | 1,064,026 | $14.89M | $13.99 | 0 | 0% |
| Q4 2024 | 1,064,026 | $16.39M | $15.40 | 0 | 0% |
| Q3 2024 | 1,064,026 | $16.66M | $15.66 | 0 | 0% |
| Q2 2024 | 1,064,026 | $15.08M | $14.17 | -3,192,078 | -75% |
| Q1 2024 | 4,256,104 | $148.79M | $34.96 | 0 | 0% |
| Q4 2023 | 4,256,104 | $161.73M | $38.00 | 0 | 0% |
| Q3 2023 | 4,256,104 | $78.10M | $18.35 | +631,922 | +17% |
| Q2 2023 | 3,624,182 | $94.08M | $25.96 | +8,799 | 0% |
| Q1 2023 | 3,615,383 | $68.22M | $18.87 | +301,600 | +9% |
| Q4 2022 | 3,313,783 | $81.65M | $24.64 | +425,923 | +15% |
| Q3 2022 | 2,887,860 | $51.84M | $17.95 | +973,268 | +51% |
| Q2 2022 | 1,914,592 | $21.73M | $11.35 | +133,357 | +7% |
| Q1 2022 | 1,781,235 | $39.69M | $22.28 | +437,745 | +33% |
| Q4 2021 | 1,343,490 | $58.67M | $43.67 | +222,000 | +20% |
| Q3 2021 | 1,121,490 | $37.36M | $33.31 | +214,400 | +24% |
| Q2 2021 | 907,090 | $24.96M | $27.52 | — | NEW |